• Home
  • About Us
    Overview
    Prize
    Management Team
    Major Subsidiaries
  • Business
    Pharmaceutical
    Fitness
  • Investor Relations
    Company Information
    Announcements and Circulars
    Financial and Other Reports
    Corporate Governance
    Arrangements on Dissemination of Corporate Communications
    IR Enquiries
  • Contact Us
  • 繁
  • 简

2026
  • 2026
    1. 2026
    2. 2025
    3. 2024
    4. 2023
    5. 2022
    6. 2021
    7. 2020
    8. 2019
    9. 2018
    10. 2017
    11. 2016
    12. 2015
    13. 2014
    14. 2013
    15. 2012
    16. 2011
  • 2026.04.23
    Circulars - [Other]NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTIFICATION OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR DATED 24 APRIL 2026, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
  • 2026.04.23
    Circulars - [Other]NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR DATED 24 APRIL 2026, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
  • 2026.04.23
    Proxy FormsAnnual General Meeting Form of Proxy
  • 2026.04.23
    Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]NOTICE OF ANNUAL GENERAL MEETING
  • 2026.04.23
    Circulars - [General Mandate / Re-election or Appointment of Director subject to Shareholders' Approval / Amendment of Constitutional Documents]PROPOSALS FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SECURITIES AND BUY BACK SHARES, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
  • 2026.04.20
    Announcements and Notices - [Amendment of Constitutional Documents / Closure of Books or Change of Book Closure Period]PROPOSED ADOPTION OF THE FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY AND CLOSURE OF REGISTER OF MEMBERS
  • 2026.04.16
    Announcements and Notices - [List of Directors and their Role and Function]LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
  • 2026.04.16
    Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]CHANGE OF EXECUTIVE DIRECTOR
  • 2026.04.01
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 31st March, 2026
  • 2026.03.27
    Announcements and Notices - [Final Results]ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
  • 2026.03.16
    Announcements and Notices - [Date of Board Meeting]DATE OF BOARD MEETING
  • 2026.03.11
    Announcements and Notices - [Profit Warning / Inside Information]PROFIT WARNING
  • 2026.03.03
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 28th February, 2026
  • 2026.02.02
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 31st January, 2026
  • 2026.01.05
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 31st December, 2025
  • About Us
    Overview Prize Management Team Major Subsidiaries
  • Business
    Pharmaceutical Fitness
  • Investor Relations
    Company Information Announcements and Circulars Financial and Other Reports Corporate Governance Arrangements on Dissemination of Corporate Communications IR Enquiries
  • Contact Us
  • © Kontafarma China Holdings Limited.
    All Rights Reserved. | Disclaimer